“This should serve as an urgent safety signal for the FDA and is more consistent with what I see in clinical practice,” said Dr. Christina Francis, a board-certified obstetrician and CEO of the American Association of Pro-Life OB/GYNs.
Politics – Latest US Political News & Headlines | New York Post
